JD-Invested Jiudian Drug Approved for IPO

2017-08-23

According to the China Securities Regulatory Commission (CSRC), Hunan Jiudian Drug Limited Company, one of JD Capital’s investees, has had its IPO application approved by the Public Offering Review Committee on August 23, and is about to go listed on the A share market.
Fy3九鼎投资(600053.SH)_上交所私募股权投资领域上市公司

Main business of the company covers R&D, production and sales of drug and technology transfer. Its products include finished products, active pharmaceutical ingredients, pharmaceutical adjuvants and plant extracts. With a comprehensive range of businesses, Jiudian Drug is listed by the Ministry of Science and Technology as a leading high-tech company with its trademark recognized as a famous trademark in Hunan Province.Fy3九鼎投资(600053.SH)_上交所私募股权投资领域上市公司

At present, Jiudian’s production departments of active pharmaceutical ingredients, both oral solid and liquid finished products, external preparation, pharmaceutical adjuvants, plant extracts and medical equipment are of national GMP standard. It also boasts state-of-the-art equipment for production and inspection.Fy3九鼎投资(600053.SH)_上交所私募股权投资领域上市公司

Furthermore, the company has strong independent R&D capacity as its tech-center has been recognized as Hunan Business Technology Center, Hunan Engineering Laboratory for New Gel Paste, and Hunan Engineering Laboratory for Respiratory Medicine. Jiudian also has a high-caliber R&D team and a well-equipped laboratory, which enables it to become a complete experiment platform capable of both minor and mid-level experiments as well as industrial transformation. It has undertaken more than 10 research projects at national or provincial level , some of which are awarded the second or third prize of technology progress by Hunan Provincial Government.Fy3九鼎投资(600053.SH)_上交所私募股权投资领域上市公司

JD Capital bought shares from Jiudian Drug Company in 2013, accounting for 10% of the total shares.Fy3九鼎投资(600053.SH)_上交所私募股权投资领域上市公司

As of now, the year 2017 witnessed nine of the JD Capital-invested companies entering the A share market. They are: Jiudian Drug, Chuanheng Chemical, Cisen Pharmaceutical, Jinneng Technology, Kelin Electric, Chengyi Pharmaceutical, Juewei Food, Boshi Glasses and Huida Sanitary Ware. Fy3九鼎投资(600053.SH)_上交所私募股权投资领域上市公司

EN | CN